Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study - Li, Jian-Ri; Wang, Shian-Shiang; Chen, Chuan-Shu; Cheng, Chen-Li; Hung, Sheng-Chun; Lin, Ching-Heng; Chiu, Kun-Yuan (PloS one, 2022)
Keywords: Age; Aged; Ambulatory care; Androgen Antagonists - adverse effects; Androgens; Antagonists; Antiandrogens; Autoimmune diseases; Biology and Life Sciences; Cancer surgery; Cancer therapies; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - chemically induced; Cardiovascular Diseases - epidemiology; Castration; Chronic illnesses; Complications and side effects; Deprivation; Diabetes; Gonadotropin-releasing hormone; Gonadotropins; Health insurance; Health risks; Humans; Hypertension; Injection; Kidney diseases; Male; Medicine and Health Sciences; Metastasis; Orchiectomy - adverse effects; Patient outcomes; Patients; Physicians; Pituitary (anterior); Population; Population studies; Population-based studies; Prostate cancer; Prostatectomy; Prostatic Neoplasms - drug therapy; Prostatic Neoplasms - epidemiology; Prostatic Neoplasms - etiology; Regression analysis; Risk; Risk factors; Therapy; Urological surgery; Variables; Taiwan